Advertisement

Topics

AndroGel Competitors Enter US After Perrigo’s Exclusivity Expires

08:09 EDT 17 Apr 2019 | SCRIP

Following the expiry of Perrigo’s 180-day exclusivity for its generic version of AndroGel, firms including Lupin and Teva have launched...

      

Related Stories

 

Original Article: AndroGel Competitors Enter US After Perrigo’s Exclusivity Expires

NEXT ARTICLE

More From BioPortfolio on "AndroGel Competitors Enter US After Perrigo’s Exclusivity Expires"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...